<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://stocktwits.com/sitemap/rss_feed.xml</title><link>https://stocktwits.com/sitemap/rss_feed.xml</link><description>Individual feed output.</description><lastBuildDate>Wed, 24 Dec 2025 11:01:06 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>Micron Stock Hits Record High Before Christmas — Futurum Equities Says Market Is Repricing Firm Toward Durable AI Margins</title><link>https://stocktwits.com/news-articles/markets/equity/micron-stock-hits-record-high-before-christmas-futurum-equities-says-market-repricing-toward-durable-ai-margins/cLeszelREvS</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>The record high comes as investors reassess Micron’s positioning in the AI-driven memory market.</description><pubDate>Wed, 24 Dec 2025 15:57:16 GMT</pubDate></item><item><title>Netflix Pushes Back On TRC Capital’s Mini-Tender Bid At Below-Market Price</title><link>https://stocktwits.com/news-articles/markets/equity/netflix-pushes-back-on-trc-capital-mini-tender-bid-at-below-market-price/cLesy0MREv0</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>TRC is looking to purchase 1.25 million shares of Netflix common stock at a price of $91 per share in cash.</description><pubDate>Wed, 24 Dec 2025 15:28:18 GMT</pubDate></item><item><title>Psychedelics Break Out Of The Fringe Under RFK Jr’s 2025 Reset — But Did MNMD Or CMPS Own The Year?</title><link>https://stocktwits.com/news-articles/markets/equity/psychedelics-break-out-under-rfk-jr-reset-mnmd-or-cmps-2025-winner/cLesx14REvi</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture2.png</image_url><description>Regulatory thaw, political backing, and late-stage data are propelling psychedelic drugmakers into the biotech spotlight — with Compass Pathways and M...</description><pubDate>Wed, 24 Dec 2025 14:52:15 GMT</pubDate></item><item><title>Omeros Stock Jumps Premarket After FDA Approves First Drug For Rare Transplant Complication — Retail Sees Big Upside</title><link>https://stocktwits.com/news-articles/markets/equity/omeros-stock-jumps-premarket-after-fda-approves-first-drug-for-rare-transplant-complication/cLesxhYREvL</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>The drug was approved for use in adults and children aged two years and older.</description><pubDate>Wed, 24 Dec 2025 14:49:37 GMT</pubDate></item><item><title>Why Did AGIO Stock Surge 14% Today?</title><link>https://stocktwits.com/news-articles/markets/equity/why-did-agio-stock-surge-14-today/cLesxI9REvh</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>Agios Pharmaceuticals announced that the FDA approved its oral therapy for anemia in adults with alpha- or beta-thalassemia.</description><pubDate>Wed, 24 Dec 2025 14:41:05 GMT</pubDate></item></channel></rss>